• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FL-QSAR:基于联邦学习的合作药物发现 QSAR 原型。

FL-QSAR: a federated learning-based QSAR prototype for collaborative drug discovery.

机构信息

Translational Medical Center for Stem Cell Therapy and Institute for Regenerative Medicine, Shanghai East Hospital, Bioinformatics Department, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.

Department of AI, WeBank, Shenzhen 518055, China.

出版信息

Bioinformatics. 2021 Apr 1;36(22-23):5492-5498. doi: 10.1093/bioinformatics/btaa1006.

DOI:10.1093/bioinformatics/btaa1006
PMID:33289524
Abstract

MOTIVATION

Quantitative structure-activity relationship (QSAR) analysis is commonly used in drug discovery. Collaborations among pharmaceutical institutions can lead to a better performance in QSAR prediction, however, intellectual property and related financial interests remain substantially hindering inter-institutional collaborations in QSAR modeling for drug discovery.

RESULTS

For the first time, we verified the feasibility of applying the horizontal federated learning (HFL), which is a recently developed collaborative and privacy-preserving learning framework to perform QSAR analysis. A prototype platform of federated-learning-based QSAR modeling for collaborative drug discovery, i.e. FL-QSAR, is presented accordingly. We first compared the HFL framework with a classic privacy-preserving computation framework, i.e. secure multiparty computation to indicate its difference from various perspective. Then we compared FL-QSAR with the public collaboration in terms of QSAR modeling. Our extensive experiments demonstrated that (i) collaboration by FL-QSAR outperforms a single client using only its private data, and (ii) collaboration by FL-QSAR achieves almost the same performance as that of collaboration via cleartext learning algorithms using all shared information. Taking together, our results indicate that FL-QSAR under the HFL framework provides an efficient solution to break the barriers between pharmaceutical institutions in QSAR modeling, therefore promote the development of collaborative and privacy-preserving drug discovery with extendable ability to other privacy-related biomedical areas.

AVAILABILITY AND IMPLEMENTATION

The source codes of FL-QSAR are available on the GitHub: https://github.com/bm2-lab/FL-QSAR.

SUPPLEMENTARY INFORMATION

Supplementary data are available at Bioinformatics online.

摘要

动机

定量构效关系 (QSAR) 分析在药物发现中被广泛应用。制药机构之间的合作可以提高 QSAR 预测的性能,但知识产权和相关的财务利益仍然严重阻碍了药物发现中 QSAR 建模的机构间合作。

结果

我们首次验证了应用水平联邦学习(HFL)的可行性,HFL 是一种最近开发的协作和隐私保护学习框架,可用于进行 QSAR 分析。相应地,提出了基于联邦学习的合作药物发现 QSAR 建模的原型平台,即 FL-QSAR。我们首先从不同角度比较了 HFL 框架与经典隐私保护计算框架(即安全多方计算)的区别。然后,我们在 QSAR 建模方面比较了 FL-QSAR 与公开合作的区别。我们的广泛实验表明:(i)FL-QSAR 的协作优于仅使用其私有数据的单个客户端,(ii)FL-QSAR 的协作几乎与使用所有共享信息的明文学习算法的协作具有相同的性能。综上所述,我们的结果表明,HFL 框架下的 FL-QSAR 为打破制药机构在 QSAR 建模方面的障碍提供了有效的解决方案,从而促进了协作和隐私保护药物发现的发展,并具有扩展到其他隐私相关生物医学领域的能力。

可用性和实现

FL-QSAR 的源代码可在 GitHub 上获得:https://github.com/bm2-lab/FL-QSAR。

补充信息

补充数据可在生物信息学在线获得。

相似文献

1
FL-QSAR: a federated learning-based QSAR prototype for collaborative drug discovery.FL-QSAR:基于联邦学习的合作药物发现 QSAR 原型。
Bioinformatics. 2021 Apr 1;36(22-23):5492-5498. doi: 10.1093/bioinformatics/btaa1006.
2
Secure multiparty computation for privacy-preserving drug discovery.安全多方计算在药物发现中的隐私保护应用。
Bioinformatics. 2020 May 1;36(9):2872-2880. doi: 10.1093/bioinformatics/btaa038.
3
The FeatureCloud Platform for Federated Learning in Biomedicine: Unified Approach.FeatureCloud 平台在生物医学领域的联邦学习:统一方法。
J Med Internet Res. 2023 Jul 12;25:e42621. doi: 10.2196/42621.
4
Multi-party collaborative drug discovery via federated learning.多方协作的药物发现:通过联邦学习。
Comput Biol Med. 2024 Mar;171:108181. doi: 10.1016/j.compbiomed.2024.108181. Epub 2024 Feb 19.
5
Predicting anticancer drug sensitivity on distributed data sources using federated deep learning.使用联邦深度学习在分布式数据源上预测抗癌药物敏感性。
Heliyon. 2023 Aug 1;9(8):e18615. doi: 10.1016/j.heliyon.2023.e18615. eCollection 2023 Aug.
6
An Integration Framework of Secure Multiparty Computation and Deep Neural Network for Improving Drug-Drug Interaction Predictions.一种安全多方计算和深度神经网络的集成框架,用于提高药物-药物相互作用预测。
J Comput Biol. 2023 Sep;30(9):1034-1045. doi: 10.1089/cmb.2023.0076. Epub 2023 Sep 14.
7
Collaborative analysis for drug discovery by federated learning on non-IID data.通过联邦学习对非独立同分布数据进行药物发现的协同分析。
Methods. 2023 Nov;219:1-7. doi: 10.1016/j.ymeth.2023.09.001. Epub 2023 Sep 9.
8
Federated Machine Learning, Privacy-Enhancing Technologies, and Data Protection Laws in Medical Research: Scoping Review.联邦机器学习、隐私增强技术和医疗研究中的数据保护法规:范围综述。
J Med Internet Res. 2023 Mar 30;25:e41588. doi: 10.2196/41588.
9
Medical federated learning with joint graph purification for noisy label learning.基于联合图净化的医学联邦学习用于噪声标签学习。
Med Image Anal. 2023 Dec;90:102976. doi: 10.1016/j.media.2023.102976. Epub 2023 Oct 4.
10
MolCFL: A personalized and privacy-preserving drug discovery framework based on generative clustered federated learning.MolCFL:基于生成式聚类联邦学习的个性化隐私保护药物发现框架。
J Biomed Inform. 2024 Sep;157:104712. doi: 10.1016/j.jbi.2024.104712. Epub 2024 Aug 23.

引用本文的文献

1
Leveraging federated learning and edge computing for pandemic-resilient healthcare.利用联邦学习和边缘计算实现抗疫情的医疗保健。
Sci Rep. 2025 Jul 1;15(1):20497. doi: 10.1038/s41598-025-00199-9.
2
Artificial intelligence in polycystic ovarian syndrome management: past, present, and future.人工智能在多囊卵巢综合征管理中的应用:过去、现在与未来
Radiol Med. 2025 Jun 23. doi: 10.1007/s11547-025-02032-9.
3
Artificial Intelligence in Molecular Optimization: Current Paradigms and Future Frontiers.分子优化中的人工智能:当前范式与未来前沿
Int J Mol Sci. 2025 May 19;26(10):4878. doi: 10.3390/ijms26104878.
4
Artificial intelligence approaches for anti-addiction drug discovery.用于抗成瘾药物发现的人工智能方法。
Digit Discov. 2025 May 13. doi: 10.1039/d5dd00032g.
5
A review of machine learning methods for imbalanced data challenges in chemistry.化学中不平衡数据挑战的机器学习方法综述。
Chem Sci. 2025 Apr 22;16(18):7637-7658. doi: 10.1039/d5sc00270b. eCollection 2025 May 7.
6
kMoL: an open-source machine and federated learning library for drug discovery.kMoL:一个用于药物发现的开源机器学习与联邦学习库。
J Cheminform. 2025 Feb 25;17(1):22. doi: 10.1186/s13321-025-00967-9.
7
Federated attention consistent learning models for prostate cancer diagnosis and Gleason grading.用于前列腺癌诊断和 Gleason 分级的联邦注意力一致性学习模型
Comput Struct Biotechnol J. 2024 Apr 5;23:1439-1449. doi: 10.1016/j.csbj.2024.03.028. eCollection 2024 Dec.
8
MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information.美乐蒂:在前所未有的规模上进行跨制药公司联邦学习,在不损害专有信息的情况下,实现 QSAR 的优势。
J Chem Inf Model. 2024 Apr 8;64(7):2331-2344. doi: 10.1021/acs.jcim.3c00799. Epub 2023 Aug 29.
9
Predicting anticancer drug sensitivity on distributed data sources using federated deep learning.使用联邦深度学习在分布式数据源上预测抗癌药物敏感性。
Heliyon. 2023 Aug 1;9(8):e18615. doi: 10.1016/j.heliyon.2023.e18615. eCollection 2023 Aug.
10
Preventing AI From Creating Biochemical Threats.防止人工智能制造生物化学威胁。
J Chem Inf Model. 2023 Feb 13;63(3):691-694. doi: 10.1021/acs.jcim.2c01616. Epub 2023 Jan 25.